JANADRIA-FESTIVAL
23.12.2018 14:48:05 CET | Business Wire | Press release
The National Festival of Heritage and Culture in Janadria, which began last Thursday, is a valuable opportunity to highlight the elements of the tangible and intangible cultural heritage of the Kingdom of Saudi Arabia on an international level. Mainly as the festival is the most important event of its kind in the world, as it attracts millions of lovers of heritage and originality from Saudi Arabia, the Arabian Gulf region and worldwide, with hundreds of local, Arab and international media who will be covering the various rich activities of the festival.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181223005010/en/
The festival reflects unique cultures, traditions and behavior from every region of the Kingdom, where there are many dialects and customs represented. This is both in the heritage of the regions, or through the folk market where the ‘Katateeb’ (traditional schools), folk games and old tales all in a traditional setting reveal simplicity and the identity of society at the time.
Urban Heritage of the Regions
The festival highlights the distinctiveness of the various areas of Saudi Arabia and their urban heritage through showing the identity of each region, as well as the heritage elements of handicrafts, folk dishes and museums.
Folk market
The Folk Market is a forum that reflects the great diversity in Saudi folklore, with the allocation of shops and workshops for each craftsman from each region in the market, which is the first nucleus in the establishment of the festival since its inception. At the Folk Market everything is displayed in a panoramic way preserving the depth and diversity of culture in one place.
Handicrafts
The National Heritage and Culture Festival is keen to support craftsmen by choosing the handicrafts for each region according to special criteria and mechanisms. More than 300 handicrafts are scattered throughout the festival.
Al Warraq
Al Warraq is one of the handicrafts that have disappeared, and this year for the first time will be in the folk market, where the public will notice the artisans specialized in the binding of books and their preservation, while using simple craft tools such as thread, needle, scissors and glue.
Women's Activities
This year, women will participate in several activities aimed at handicrafts and productive families, as well as highlighting the role of people with special needs. There will also be professional courses for visitors.
The Traditional Farm
The Traditional Farm was the main source of livelihood for some and displayed will be the means of plowing and chanting that echoed from the farmers during their work.
Katateeb School (Traditional School)
On display will be an imitation of the Mutawa (the traditional teacher) and his students, with a courtyard next to the school for old folk games.
*Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20181223005010/en/
Contact:
Pyramedia Reham Barakat reham.barakat@pyramedia.biz
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom